MedPath

A Phase II Study of SI-613 in Patients with Knee Osteoarthritis (repeat-dose study)

Not Applicable
Conditions
Knee Osteoarthritis
Registration Number
JPRN-UMIN000015858
Lead Sponsor
SEIKAGAKU CORPORATIO
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
160
Inclusion Criteria

Not provided

Exclusion Criteria

-Patients with secondary OA resulting from trauma or other diseases -Patients with risk of infection in the area of the injection site due to skin disease or infection.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath